Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 45
Results: 10
C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21<sup>waf1/cip1</sup> promoter.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6027, doi. 10.1038/onc.2010.338
- By:
- Publication type:
- Article
Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6016, doi. 10.1038/onc.2010.337
- By:
- Publication type:
- Article
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6051, doi. 10.1038/onc.2010.335
- By:
- Publication type:
- Article
Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6071, doi. 10.1038/onc.2010.333
- By:
- Publication type:
- Article
RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6040, doi. 10.1038/onc.2010.328
- By:
- Publication type:
- Article
A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 5989, doi. 10.1038/onc.2010.341
- By:
- Publication type:
- Article
MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6084, doi. 10.1038/onc.2010.472
- By:
- Publication type:
- Article
Serine/threonine phosphatases in the DNA damage response and cancer.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 5977, doi. 10.1038/onc.2010.371
- By:
- Publication type:
- Article
Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6004, doi. 10.1038/onc.2010.336
- By:
- Publication type:
- Article
Interfering with RAS-effector protein interactions prevent RAS-dependent tumour initiation and causes stop-start control of cancer growth.
- Published in:
- Oncogene, 2010, v. 29, n. 45, p. 6064, doi. 10.1038/onc.2010.346
- By:
- Publication type:
- Article